Geneos Wealth Management
RDY icon

Geneos Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Geneos Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-407
Closed -$6.12K – 3027
2025
Q2 		$6.12K Buy
407
+158
+63% +$2.26K ﹤0.01% 2509
2025
Q1 		$3.28K Buy
+249
New +$3.44K ﹤0.01% 2638
2021
Q2 		– Sell
-145
Closed -$2K – 3061
2021
Q1 		$2K Buy
+145
New +$1.86K ﹤0.01% 2921

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geneos Wealth Management's RDY Position: Q3 2025 in Review

Geneos Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2025, closing a stake of 407 shares — an estimated $6.12K sold.

Geneos Wealth Management first reported a position in RDY in Q1 2021 and held it in 3 quarters. The position peaked at $6.12K in Q2 2025. 228 funds tracked by Wall St. Rank hold RDY as of Q3 2025.

  • Geneos Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2025 after selling out during the quarter.
  • Geneos Wealth Management sold 407 Dr. Reddy's Laboratories shares in Q3 2025, an estimated $6.12K.
  • Geneos Wealth Management first reported a position in Dr. Reddy's Laboratories in Q1 2021 and held it in 3 quarters.
  • Geneos Wealth Management's Dr. Reddy's Laboratories position peaked at $6.12K in Q2 2025.
  • 228 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2025.

Based on Geneos Wealth Management's 13F filing for Q3 2025, filed 22 Oct 2025.